v3.26.1
The effects of the restatement on the previously issued financial statements presented or otherwise required to be disclosed in this Quarterly Report are set forth below. (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Error Corrections and Prior Period Adjustments Restatement [Line Items]                
Inventories, net $ 12,957 $ 13,815     $ 12,957   $ 14,963  
Total current assets 25,270 22,672     25,270   25,228  
Total assets 46,437 44,050     46,437   46,507  
Accumulated deficit (103,306) (103,148)     (103,306)   (102,186)  
Total stockholders' equity 13,154 13,223 $ 14,424 $ 10,826 13,154 $ 14,424 14,086 $ 10,353
Total liabilities and stockholders’ equity 46,437 44,050     46,437   46,507  
Cost of revenue 10,584 9,816 13,916   20,400 24,895    
Gross profit 4,748 3,141 6,443   7,890 10,089    
Research and development expense 947 1,042 955   1,990 1,973    
Selling, general and administrative expense 3,680 2,799 3,012   6,479 5,120    
Operating income (loss) 121 (700) 2,476   (579) 2,996    
Interest expense, net 279   87   543 263    
Other income, net   1,234   2 1,234    
Loss before income taxes (158) (962) 3,623   (1,120) 3,967    
Provision for income taxes 390   390    
Net income (loss) $ (158) $ (962) $ 3,233 343 $ (1,120) $ 3,577    
Net income (loss) per share-basic $ (0.00) $ (0.01) $ 0.04   $ (0.02) $ 0.05    
Net income (loss) per share-diluted $ (0.00) $ (0.01) $ 0.04   $ (0.02) $ 0.05    
Weighted-average shares — basic 70,637,199   70,200,039   70,631,380 70,151,928    
Weighted-average shares — diluted 70,637,199   72,580,679   70,631,380 72,497,929    
Inventories, net         $ 2,006 $ (395)    
Net cash used in operating activities         1,708 (7,875)    
Net increase in cash         (242) 2,699    
Cash at end of period $ 1,046   $ 4,108   1,046 4,108    
Retained Earnings [Member]                
Error Corrections and Prior Period Adjustments Restatement [Line Items]                
Total stockholders' equity (103,306) $ (103,148) (102,186) (104,678) $ (103,306) (102,186) (102,186) (105,021)
Net income (loss) $ (158) (962) 3,233 343        
Previously Reported [Member]                
Error Corrections and Prior Period Adjustments Restatement [Line Items]                
Inventories, net   17,559         18,511  
Total current assets   26,413         28,776  
Total assets   47,794         50,055  
Accumulated deficit   (99,404)         (98,638)  
Total stockholders' equity   16,967 18,188     18,188 17,634 14,946
Total liabilities and stockholders’ equity   47,794         50,055  
Cost of revenue   9,620 14,482     25,725    
Gross profit   3,337 5,877     9,259    
Research and development expense   1,042 955     1,973    
Selling, general and administrative expense   2,799 3,012     5,120    
Operating income (loss)   (504) 1,910     2,166    
Interest expense, net     87     263    
Other income, net     1,234     1,234    
Loss before income taxes   (766) 3,057     3,137    
Provision for income taxes   390     390    
Net income (loss)   $ (766) $ 2,667 80   $ 2,747    
Net income (loss) per share-basic   $ (0.01) $ 0.04     $ 0.04    
Net income (loss) per share-diluted   $ (0.01) $ 0.04     $ 0.04    
Weighted-average shares — basic     70,200,039     70,151,928    
Weighted-average shares — diluted     72,580,679     72,497,929    
Inventories, net           $ 435    
Net cash used in operating activities           (7,875)    
Net increase in cash           2,699    
Cash at end of period     $ 4,108     4,108    
Previously Reported [Member] | Retained Earnings [Member]                
Error Corrections and Prior Period Adjustments Restatement [Line Items]                
Total stockholders' equity     (97,681)     (97,681)   (100,428)
Revision of Prior Period, Error Correction, Adjustment [Member]                
Error Corrections and Prior Period Adjustments Restatement [Line Items]                
Inventories, net   $ (3,744)         (3,548) (4,613)
Total current assets   (3,744)         (3,548)  
Total assets   (3,744)         (3,548)  
Accumulated deficit   (3,744)         (3,548)  
Total stockholders' equity   (3,744) (3,764)     (3,764) (3,548) (4,593)
Total liabilities and stockholders’ equity   (3,744)         $ (3,548)  
Cost of revenue   196 (566)     (830)    
Gross profit   (196) 566     830    
Research and development expense          
Selling, general and administrative expense          
Operating income (loss)   (196) 553     830    
Interest expense, net            
Other income, net            
Loss before income taxes   (196) 553     830    
Provision for income taxes          
Net income (loss)   $ (196) $ 566 $ 263   $ 830    
Net income (loss) per share-basic   $ 0.00     $ 0.01    
Net income (loss) per share-diluted   $ 0.00     $ 0.01    
Weighted-average shares — basic            
Weighted-average shares — diluted            
Inventories, net           $ (830)    
Net cash used in operating activities              
Net increase in cash              
Cash at end of period            
Revision of Prior Period, Error Correction, Adjustment [Member] | Retained Earnings [Member]                
Error Corrections and Prior Period Adjustments Restatement [Line Items]                
Total stockholders' equity     $ (4,505)     $ (4,505)   $ (4,593)